Melanoma Journal Articles for December 2019
British Journal of Dermatology
Does polygenic risk influence associations between sun exposure and melanoma? A prospective cohort analysis
C.M. Olsen N. Pandeya M.H. Law S. MacGregor M.M. Iles B.S. Thompson A.C. Green R.E. Neale D.C. Whiteman for the QSkin Study
First published: 20 November 2019 https://doi.org/10.1111/bjd.18703
Neck Melanoma: Clinical, Dermoscopic and Confocal FeaturesBorsari S.a · Pampena R.a · Raucci M.a · Mirra M.a · Piana S.b · Pellacani G.c · Longo C.a,c |
https://doi.org/10.1159/000503284 Dermatology
NEDD4 Negatively Regulates GITR via Ubiquitination in Immune Microenvironment of Melanoma
Authors Guo Y, Yang L, Lei S, Tan W, Long J
Received 15 April 2019
Accepted for publication 6 November 2019
Published 4 December 2019 Volume 2019:12 Pages 10629—10637
DOI https://doi.org/10.2147/OTT.S212317
Journal of the European Academy of Dermatology and Venereolgy
Late recurrence of melanoma after ten years ? is the course of the disease different from early recurrences?
First published: 23 November 2019 https://doi.org/10.1111/jdv.16106
Science Advances
Molecular phenotyping and image-guided surgical treatment of melanoma using spectrally distinct ultrasmall core-shell silica nanoparticles
Feng Chen1,*, Brian Madajewski1,*, Kai Ma2,*, Daniella Karassawa Zanoni3, Hilda Stambuk1, Melik Z. Turker2, Sébastien Monette4, Li Zhang1, Barney Yoo1, Peiming Chen1, Richard J. C. Meester5, Sander de Jonge5, Pablo Montero3, Evan Phillips1,†, Thomas P. Quinn6,7, Mithat Gönen8, Sonia Sequeira9, Elisa de Stanchina10, Pat Zanzonico11, Ulrich Wiesner2,‡, Snehal G. Patel3,‡ and Michelle S. Bradbury1,12,‡
Science Advances 04 Dec 2019:
Vol. 5, no. 12, eaax5208
DOI: 10.1126/sciadv.aax5208
The Lancet Oncology
Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1–2 trial
Birgit Geoerger, MD Hyoung Jin Kang, MD Michal Yalon-Oren, MD Lynley V Marshall, PhD Catherine Vezina, MD Alberto Pappo, MD et al.
Published:December 04, 2019DOI:https://doi.org/10.1016/S1470-2045(19)30671-0
Human Reproduction
Hormone replacement therapy and the risk of melanoma in post-menopausal women
B M Hicks, K B Kristensen, S A Pedersen, L R Hölmich, A Pottegård
Human Reproduction, dez222, https://doi.org/10.1093/humrep/dez222
Published: 05 December 2019
British Journal of Dermatology
The interplay of sun?damage and genetic risk in Australian multiple and single primary melanoma cases and controls
E.K. McMeniman, D.L. Duffy, K. Jagirdar, K.J. Lee, E. Peach, A.M. McInerney?Leo, B. De’Ambrosis, J.E. Rayner, B.M. Smithers, H.P. Soyer, R.A. Sturm
First published: 03 December 2019 https://doi.org/10.1111/bjd.18777
The Lancet
Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1–2 trial
Birgit Geoerger, MD , Hyoung Jin Kang, MD, Michal Yalon-Oren, MD, Lynley V Marshall, PhD, Catherine Vezina, MD, Alberto Pappo, MD, et al.
Published:December 04, 2019DOI:https://doi.org/10.1016/S1470-2045(19)30671-0
Molecular Cell
Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma
Marie R. Webster,1,10,12, * Mitchell E. Fane,1 Gretchen M. Alicea,1,3 Subhasree Basu,2 Andrew V. Kossenkov,4 Gloria E. Marino,1 Stephen M. Douglass,1 Amanpreet Kaur,1,3 Brett L. Ecker,1,5 Keerthana Gnanapradeepan,2,6 Abibatou Ndoye,1,3 Curtis Kugel,1 Alexander Valiga,1 Jessica Palmer,1 Qin Liu,2 Xiaowei Xu,7 Jessicamarie Morris,1 Xiangfan Yin,2 Hong Wu,8 Wei Xu,7 Cathy Zheng,7 Giorgos C. Karakousis,7 Ravi K. Amaravadi,7 Tara C. Mitchell,7 Filipe V. Almeida,1 Min Xiao,1 Vito W. Rebecca,1 Ying-Jie Wang,9 Lynn M. Schuchter,7 Meenhard Herlyn,1 Maureen E. Murphy,2 and Ashani T. Weeraratna1,11
https://doi.org/10.1016/j.molcel.2019.11.009
Cancer
Quantitative associations between health insurance and stage of melanoma at diagnosis among nonelderly adults in the United States
Boya Abudu MD, MPH, Kaitlyn A. Cook MA , Jeffrey E. Gershenwald MD, Philip R. Cohen MD, Alan C. Geller MPH, RN
First published: 12 November 2019 https://doi.org/10.1002/cncr.32587
Journal of the National Cancer Institute
Association of Indoor Tanning Exposure With Age at Melanoma Diagnosis and BRAF V600E Mutations
Toni E Burbidge, Boris C Bastian, Danny Guo, Haocheng Li, Don G Morris, Jose G Monzon, Gabriella Leung, Huiming Yang, Tina Cheng
JNCI: Journal of the National Cancer Institute, Volume 111, Issue 11, November 2019, Pages 1228–1231, https://doi.org/10.1093/jnci/djz048
Published: 28 March 2019
Journal of the national comprehensive cancer network
Association Between Hospital Volume, Therapy Types, and Overall Survival in Stage III and IV Cutaneous Malignant Melanoma
Authors: Sri Harsha Tella a , Anuhya Kommalapati a , b , Apar Kishor Ganti c , d and Alissa S. Marr c
Volume/Issue: Volume 17: Issue 11
Online Publication Date: Nov 2019
DOI: https://doi.org/10.6004/jnccn.2019.7320